These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 20468056)

  • 1. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
    Ching MS; Shen Y; Tan WH; Jeste SS; Morrow EM; Chen X; Mukaddes NM; Yoo SY; Hanson E; Hundley R; Austin C; Becker RE; Berry GT; Driscoll K; Engle EC; Friedman S; Gusella JF; Hisama FM; Irons MB; Lafiosca T; LeClair E; Miller DT; Neessen M; Picker JD; Rappaport L; Rooney CM; Sarco DP; Stoler JM; Walsh CA; Wolff RR; Zhang T; Nasir RH; Wu BL;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):937-47. PubMed ID: 20468056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay.
    Wiśniowiecka-Kowalnik B; Nesteruk M; Peters SU; Xia Z; Cooper ML; Savage S; Amato RS; Bader P; Browning MF; Haun CL; Duda AW; Cheung SW; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):983-93. PubMed ID: 20162629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
    Schaaf CP; Boone PM; Sampath S; Williams C; Bader PI; Mueller JM; Shchelochkov OA; Brown CW; Crawford HP; Phalen JA; Tartaglia NR; Evans P; Campbell WM; Tsai AC; Parsley L; Grayson SW; Scheuerle A; Luzzi CD; Thomas SK; Eng PA; Kang SH; Patel A; Stankiewicz P; Cheung SW
    Eur J Hum Genet; 2012 Dec; 20(12):1240-7. PubMed ID: 22617343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of speech and language phenotype in children with NRXN1 deletions.
    Brignell A; St John M; Boys A; Bruce A; Dinale C; Pigdon L; Hildebrand MS; Amor DJ; Morgan AT
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):700-708. PubMed ID: 30358070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature.
    Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.
    Yuan H; Wang Q; Liu Y; Yang W; He Y; Gusella JF; Song J; Shen Y
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):589-595. PubMed ID: 30076746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.
    Shinawi M; Liu P; Kang SH; Shen J; Belmont JW; Scott DA; Probst FJ; Craigen WJ; Graham BH; Pursley A; Clark G; Lee J; Proud M; Stocco A; Rodriguez DL; Kozel BA; Sparagana S; Roeder ER; McGrew SG; Kurczynski TW; Allison LJ; Amato S; Savage S; Patel A; Stankiewicz P; Beaudet AL; Cheung SW; Lupski JR
    J Med Genet; 2010 May; 47(5):332-41. PubMed ID: 19914906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.
    Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA
    Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further insight into the neurobehavioral pattern of children carrying the 2p16.3 heterozygous deletion involving NRXN1: Report of five new cases.
    Alfieri P; Scibelli F; Sinibaldi L; Valeri G; Caciolo C; Novello RL; Novelli A; Digilio MC; Tartaglia M; Vicari S
    Genes Brain Behav; 2020 Sep; 19(7):e12687. PubMed ID: 32658356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series - further understanding of the relevance of NRXN1 to neurodevelopmental disorders.
    Curran S; Ahn JW; Grayton H; Collier DA; Ogilvie CM
    J Mol Psychiatry; 2013; 1(1):4. PubMed ID: 25408897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
    Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
    Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
    Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
    J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
    Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
    Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations.
    Mertz LG; Thaulov P; Trillingsgaard A; Christensen R; Vogel I; Hertz JM; Ostergaard JR
    Res Dev Disabil; 2014 Jul; 35(7):1742-7. PubMed ID: 24656292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.